Adherium
Generated by Meeveem AI
"Digital respiratory monitoring technology that improves medication adherence for asthma and COPD."
Melbourne, VIC
•11 - 50 Employees
•Medical Devices
About Adherium
Adherium develops smart inhaler technology and cloud data solutions for chronic respiratory disease. Hailie Smartinhaler sensors attach to asthma and COPD inhalers, capturing real-time medication use and transmitting data to physicians, payers, and patients. This enables clinicians to identify non-adherence early, adjust treatments remotely, and reduce preventable hospital admissions. The technology addresses medication non-adherence, which contributes 34 billion dollars annually in preventable US healthcare costs. By integrating devices and data, Adherium empowers physicians to optimise patient outcomes, supports payers in managing costs, and helps patients with difficult-to-treat conditions achieve better disease control.
40
Team Members
2001
Founded
Medical Devices
Sector
Hybrid
Work Environment
Our Vision
A world where respiratory disease is managed through integrated digital solutions that optimise outcomes for patients, healthcare professionals, and payers.
Our Mission
At Adherium, our mission is to improve health outcomes in chronic respiratory disease by providing digital adherence monitoring and remote patient management solutions.